Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
CPHRF | OTC Markets | USD | Delayed | |
CPH | CBOE Canada | CAD | Real-time | |
CPH | Toronto | CAD | Real-time |
For the three months ended 31 March 2022, Cipher Pharmaceuticals Inc revenues decreased 1% to $5.4M. Net income increased 60% to $2.1M. Revenues reflect Licensing revenue decrease of 24% to $2.1M. Net income reflects Provision for legal settlement decrease from $1.3M (expense) to $0K, Foreign exchange (gain) loss increase from $32K (expense) to $17K (income), Interest expense decrease from $39K (expense) to $0K.
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 5.42 | 5.85 | 4.51 | 6.13 |
Gross Profit | 4.29 | 4.92 | 3.72 | 5.09 |
Operating Income | 2.9 | 4 | 1.92 | 3.82 |
Net Income | 2.15 | 2.81 | 0.79 | 2.82 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 54 | 51.65 | 46.39 | 48.07 |
Total Liabilities | 13.65 | 12.75 | 9.55 | 11.71 |
Total Equity | 40.35 | 38.9 | 36.85 | 36.37 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | 2.1 | 13.81 | 8.1 | 7.59 |
Cash From Investing Activities | 0 | 0 | 0 | |
Cash From Financing Activities | -0.74 | -2.47 | -1.69 | -0.65 |
Net Change in Cash | 1.3 | 11.41 | 6.49 | 6.93 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review